Contact
Please use this form to send email to PR contact of this press release:
Sermonix Pharmaceuticals Announces Dr. Anthony H. Wild as Board Chairman and Investor
TO:
Please use this form to send email to PR contact of this press release:
Sermonix Pharmaceuticals Announces Dr. Anthony H. Wild as Board Chairman and Investor
TO: